Rheumatology Headlines

(ANCA)-Associated Vasculitis Indicative of Long-term Outcomes

Early Disease Management in ANCA-Associated Vasculitis Indicative of Long-term Outcomes

Disease status as early as three and six months may predict long-term outcomes in antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) patients, a study has found.  Researchers analyzed the CYCAZAREM, NORAM, MEPEX & CYCLOPS trials and long-term registry data. They evaluated patients at...

Latest Abstracts

This Week's Featured Journal: Rheumatology

click me